Therefore, cerebrovascular protein can affect the occurrence and development of atherosclerosis by inhibiting the activation of NLRP3, which can be used as a potential drug target for the prevention and treatment of atherosclerosis in the future. The gene discussed is NLRP3; the disease is atherosclerosis.